Enestebol
![]() | |
![]() | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| Identifiers | |
| |
| Synonyms | 4,17β-Dihydroxy-17α-methylandrosta-1,4-dien-3-one |
| CAS Number |
2320-86-7 |
| PubChem (CID) | 208919 |
| ChemSpider |
16736606 |
| UNII |
LNS3MVH7NV |
| ChEMBL |
CHEMBL2104239 |
| Chemical and physical data | |
| Formula | C20H28O3 |
| Molar mass | 316.43 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| | |
Enestebol (INN), also known as 4-hydroxy-17α-methyl-δ1-testosterone, as well as 4,17β-dihydroxy-17α-methylandrosta-1,4-dien-3-one, is an orally active anabolic-androgenic steroid (AAS) and a 17α-alkylated derivative of testosterone that was never marketed.[1] It is closely related to oxymesterone (4-hydroxy-17α-methyltestosterone).
See also
References
- ↑ J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 417–. ISBN 978-1-4757-2085-3.
This article is issued from Wikipedia - version of the 11/30/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.

